Re: INSM1 is a novel prognostic neuroendocrine marker for luminal B breast cancer: author reply

Pathology. 2021 Feb;53(2):293-294. doi: 10.1016/j.pathol.2020.12.002. Epub 2020 Dec 28.

Authors

Huda Razvi¹, Julia Y Tsang¹, Gary M Tse²

Affiliations

¹ Department of Anatomical and Cellular Pathology, Prince of Wales Hospital, The Chinese University of Hong Kong, Shatin, NT, Hong Kong.
² Department of Anatomical and Cellular Pathology, Prince of Wales Hospital, The Chinese University of Hong Kong, Shatin, NT, Hong Kong. Electronic address: garytse@cuhk.edu.hk.

PMID: 33384156
DOI: 10.1016/j.pathol.2020.12.002

No abstract available

Publication types

Letter
Comment

MeSH terms

Breast Neoplasms* / diagnosis
Female
Humans
Immunohistochemistry
Neuroendocrine Tumors* / diagnosis
Prognosis
Repressor Proteins

Substances

Repressor Proteins
INSM1 protein, human